Establishing a robust single-use systems (SUS) interchangeability program can be a pivotal feature of a supply chain resiliency initiative.
- The In Vivo Cell Therapy Shift On Display At PMWC 2026
- Inside SynaptixBio's Mission To Develop A Therapy For H-ABC
- 5 QMS Blind Spots You Should Know About
- New MIT Consortium Links Innovation With Real-World Biomanufacturing
- Injecting Cancer Killers: Intratumoral Therapy For Solid Tumors
- Proteomics Tools: A Resurrection
- Powering AI And Synthetic Biology In Therapy Design
- Six Specialized Modalities Testing CDMO Readiness In 2026
CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Development And Optimization Of LNP Formulations
The production of lipid nanoparticles (LNPs) is a process that demands robustness, scalability, and reproducibility. Examine the impact of key operational parameters on the efficacy of LNPs.
-
Direct Inoculation From Cryopreserved Cell Banks Using An Automated FBR
Directly inoculated your HEK293 cells into the bioreactor from cryopreservation vials or bags just using this fixed bed bioreactor (FBR) system's automated process steps.
-
Developing And Validating Clinical Receptor Occupancy Pharmacodynamic Biomarker Assays
Receptor occupancy (RO) assays assess drug-target engagement and support PK/PD modeling. Accurate RO requires customized assays using stabilized blood to monitor CD6 modulation in autoimmune therapy.
-
How To Successfully Isolate Your T Cells
Explore the results of a study focusing on the early stages of the CAR T cell workflow, specifically the initial washing of leukapheresis followed by the isolation of T cells.
-
A Comparative Study Of Cryopreservation Media
This study compared two different cryopreservation mediums and the data highlights which is ideal for preserving the viability of different cell types, including Mesenchymal Stem and HEK-293 Cell Line.
-
Expert Insights In Navigating CGT's Complex Supply Chain
Examine insights shared during Cencora's ThinkLive Cell and Gene Therapy Summit 2024 that shed light on the challenges and opportunities in navigating the complexities of the cell and gene supply chain.
-
Multiplex Imaging
Explore recombinant antibody reagents that support the imaging of key targets within the TME and offer flexible solutions across various platforms to improve patient outcomes.
-
Economic Advantage Of Robotic Gloveless Pharmaceutical Isolators
Are robotic gloveless isolators the key to smarter, safer, scalable solutions? Discover how they can revolutionize aseptic filling by reducing contamination, minimizing waste, and enhancing manufacturing flexibility.
-
Explore A High-Performing Basal Medium And Feed Pairing
A customer sought to replace a chemically defined CHO medium with a more efficient medium and feed pairing strategy in bioreactors.
-
Virus Retention Performance Under Diverse Processing Conditions
Virus filtration is robust across a wide range of process parameters, including high protein concentration and flow decay. Discover how retention relies on size exclusion to simplify risk assessment.
NEWSLETTER ARCHIVE
- 03.12.26 -- Six Specialized Modalities Testing CDMO Readiness In 2026
- 03.11.26 -- Are You Scaling CGT Wrong?
- 03.11.26 -- Regulators Maintain Consistent Endpoints While Raising Evidence Standards
- 03.10.26 -- STREAM Edition: mRNA Hot Takes: Fighting Complacency And "Alternative Facts" In 2026
- 03.10.26 -- The Real Reason We Haven't Fully Automated Cell Therapy Yet
CELL AND GENE CONTENT COLLECTIONS
While there are opportunities to scale, there are also manufacturing gaps, capacity issues, and production timelines that require improvement to do so. And then, of course, there’s cost. Because scale up and scale out are significant to everyone in the sector, we’ve curated insightful editorial that addresses the most important aspects of scalability.
More Content Collections